Background-Previous studies have reported conflicting findings regarding how the incidence
Introduction
Heart failure (HF) is a common and well-recognized complication during hospitalization for acute myocardial infarction (AMI) that is associated with substantially higher risk of death. [1] [2] [3] [4] In contrast, the incidence of HF occurring after AMI is less well characterized. Trends in the incidence of HF following AMI have been examined in two surveillance cohorts, but the findings from these studies have been conflicting-data from Olmsted County indicated that the incidence of HF after AMI has decreased from 1979 to 1994, 5 while data from the Framingham Heart Study suggested an increase in HF incidence after AMI from 1970 to 1999. 6 However, both of these study cohorts were relatively small, were constrained to demographically and geographically homogeneous populations, and did not represent subsequent HF incidence in the context of contemporary management strategies for AMI.
As such, there is little contemporary data on HF incidence after AMI in practice settings that reflect modern management of AMI. Rapid adoption of routine invasive strategies 7 and intensive pharmacotherapy [8] [9] [10] may have improved myocardial salvage following AMI, thus lowering the subsequent risk of developing HF. On the other hand, improving survival from AMI may have created a population with greater residual myocardial injury and higher risk for developing HF. 6 Complicating matters is that the overall incidence of AMI itself has decreased in the past decade 9, 11 which may have resulted in AMI cohorts that increasingly have consisted of patients who break through intensive pharmacotherapy and who are thus at different levels of risk for developing HF.
Accordingly, we sought to examine recent national trends in the incidence and outcomes of patients with HF hospitalization following AMI using a complete sample of fee-for-service
Medicare beneficiaries hospitalized for AMI from 1998 to 2010. This analysis provides insight geographically homogeneous populations, and did not represent subsequent HF in in nci ci ide de enc nc nce e e in in in t th he context of contemporary management strategies for AMI.
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Methods

Data Sources
A complete sample of fee-for-service Medicare beneficiaries who were hospitalized from 1998 to 2011 was identified using inpatient MedPAR files from the Centers for Medicare and Medicaid Services (CMS). These administrative billing claims included information on patient demographics (age, sex, race), admission and discharge dates, and principal and secondary diagnosis codes as coded by the International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM). Medicare denominator files were used to ascertain beneficiary eligibility and enrollment in fee-for-service Medicare.
Cohort inclusion and exclusion criteria
Subjects were included in the study cohort if they were discharged alive from an acute-care hospital for a principal discharge diagnosis of AMI with ICD-9-CM codes of 410.xx between 1998 and 2010. We excluded patients with a principal discharge diagnosis of ICD-9CM codes 410.x2, as these represent subsequent episodes of AMI care. Patients admitted and discharged alive within the same day also excluded, as these episodes of care unlikely represented AMI. We also excluded 1) beneficiaries <65 years of age; 2) beneficiaries without at least 1 year of Medicare fee-for-service enrollment after their index AMI hospitalization in order to fully assess District of Columbia or Puerto Rico; and 4) beneficiaries with conflicting dates of death and hospitalization. The unit of observation for this study was a hospital admission for AMI for a particular Medicare fee-for-service beneficiary in a particular calendar year. If a beneficiary had more than one AMI admission during a given calendar year, we selected one AMI admission at random as the index hospitalization for the study cohort in order to estimate a representative risk for subsequent HF hospitalization for each calendar year. For patients who were subsequently transferred to another acute-care hospital for AMI after an initial AMI hospitalization, the hospitalization after transfer was considered as the index AMI hospitalization.
Outcomes
Our first study outcome was to evaluate changes in HF hospitalization within 1 year of AMI, as defined by an admission to an acute-care hospital for a principal discharge diagnosis of HF as defined by following ICD- 
Statistical analysis
Baseline characteristics of the cohort were tabulated across four time periods (1998-2001, 2002-2004, 2005-2007, 2008-2010 years or older), sex, and race (white, black, other). Race was ascertained using the Medicare denominator file, which uses patient-reported data from the Social Security Administration.
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Coexisting illnesses were classified according to the categorization used by CMS for the AMI 30-day mortality measure. 13 To evaluate the statistical significance of changes across years in patient characteristics, we used the chi-squared test for age and race categories, analysis of Our first study outcome was to evaluate changes in HF hospitalization within 1 y y yea ear r r of of of A A AMI MI MI, , as a n defined by an admission to an acute-care hospital for a principal discharge diagnosis of HF as were constructed to evaluate how the incident risk ratio (IRR) for HF hospitalization after AMI changed for a given calendar year compared with the baseline year of 1998; in these models age and sex were aggregated to the year-level.
For the mortality analysis, we considered the admission date of the HF hospitalization following AMI as the initial "time zero" in order to calculate the proportion of patients who died within 1 year. Mortality was reported in terms of proportion of patients who died within 30-, 90-, 180-days and 1 year. Trends in unadjusted HF mortality after AMI were assessed using regression models with a continuous variable of cohort year. We then constructed Cox proportional hazards models to examine changes in mortality after HF following AMI, adjusting for demographics and comorbid conditions. These models included dummy indicator variables that represented how the hazard ratio (HR) for mortality changed for a given calendar year compared with the baseline year of 1998.
Analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, North Carolina). Significance level was considered to be p<0.01 using two-sided tests. Institutional
Review Board review and approval was obtained through the Yale University Human
Investigation Committee. Medicare claims data were provided through a data use agreement with CMS.
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Results
Baseline characteristics of AMI cohort
The study cohort consisted of 2,789,943 AMI hospitalizations from 1998 to 2010. The overall cohort was elderly with mean age of 78.5 years, (standard deviation 8.0) with a slight male predominance (50.2%). The cohort became significantly older in more recent subgroups from 1998 to 2010, with mean age increasing from 78.1 to 78.9 years (p<0.0001). The proportion of patients coded with pre-existing HF or HF during the AMI hospitalization was high over the study period (range 40.2%-40.5%). Specific comorbidities noted with increased prevalence over time included renal failure (8.0% to 27.9%) and disorders of fluid, electrolyte and acid-base (10.9% to 18.9%). (p<0.001) ( Table 1 ) Some other comorbidities exhibited statistically significant changes over time due to large numbers, but were stable in terms of absolute differences.
HF hospitalization following AMI
A total of 366,841 patients were hospitalized for HF within a year of discharge from an AMI following AMI from 1998 to 2010 were observed across all age and race-sex groups. After adjusting for demographic factors using a Poisson model, the overall risk of HF hospitalization within 1 year after AMI declined by a relative 14.6% over the study period (IRR=0.854, 95% CI 0.809 to 0.901). (Table 3 ).
Mortality after HF hospitalization following AMI
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Discussion
Using a complete sample of fee-for-service Medicare beneficiaries, our study found that the incidence of HF hospitalization following AMI decreased from 1998 to 2010. The observed 1-year mortality for patients hospitalized for HF after AMI remains high at 45.5% in 2010, and has increased since 2007.
Our analysis extends prior work examining trends in HF hospitalizations after AMI.
While previous studies had the benefit of clinical confirmation of AMI and HF, they were limited to small geographic settings, consisted of homogenous demographic populations, and evaluated subjects prior to the introduction of modern AMI strategies. As such it is not surprising that long-term secular trends in HF incidence after AMI were conflicting. Researchers examining the Olmsted County cohort reported that the 5-year incidence of HF after AMI decreased from 0.974 to 0. 
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The decrease in HF hospitalizations after AMI may also reflect a shift towards increased surveillance of HF in the outpatient setting, resulting in greater HF diagnosis and treatment that reduces the need for hospitalization. A Canadian study found that the HF hospitalization rate has declined faster than outpatient and emergency department encounters, suggesting that some of the decline in HF admissions may be attributed towards outpatient care settings. 18 Whether this phenomenon exists for HF patients in the U.S. remains to be investigated.
Several studies have examined how HF incidence differs across race and sex, [19] [20] [21] but few have examined differences specifically in post-infarction cohorts. Our study found that HF hospitalization after AMI decreased for all race-sex groups, but black patients and women continue to suffer an excess absolute burden from HF. The explanation for why black and female subject have higher risk of HF after AMI is likely multi-factorial-differences in AMI treatments, secondary prevention of cardiovascular risk factors, and care settings all may play a role. For example, one study reported that after AMI black patients had higher rates of death, re-hospitalization, angina, and lower quality of life compared with white patients, but these differences did not persist after adjusting for patient factors and site of care. 22 Many studies have reported lower rates of coronary interventions after AMI for black and female patients, 23, 24 25, 26 which may alter the completeness of revascularization and subsequent risk for HF. Differences in declined faster than outpatient and emergency department encounters, suggestin ng g g th th hat at s s som om ome e e of of he decline in HF admissions may be attributed towards outpatient care settings. 18 Whether this ph hen en enom om omen en non on o exi xist st sts s s for HF patients in the U.S. r rem em ema ains to be inves es stiga ate te ted d d. hospitalizatio on n n af af a te te ter r r AM AM AMI de de decr cr c ea ea as s sed ed d f for or r a a all ll ll r r rac ac ace-e-e se se s x x x gr gr g ou ou ups ps ps, , bu bu but t t bl b b ac ac ack k k pa pa pati ti tien en ents ts s a a and nd nd w w wom o en rates of HF after AMI may also be due to differences in competing risks due to noncardiovascular deaths, which appears particularly influential for black men. 21 Our study illustrates that black and female patients continue have higher incidence of HF after AMI, similar to the pre-infarction setting; additional efforts towards improving the care and outcomes of these high risk groups are needed. The HF hospitalization rate after AMI declined somewhat more slowly than the overall HF hospitalization rate in general Medicare population. HF with studies demonstrating that quality of care for HF patients has improved in terms of increased use of HF pharmacotherapies. 28, 29 Alternatively, mortality may have increased due to higher atherosclerotic burden or increased severity of comorbidities over time. For example, the prevalence of renal failure increased more than three-fold over the study period, which may indicate a greater extent of cardiovascular disease for AMI patients who subsequently develop HF in recent years. While mortality continued to increase after 2007 even after adjusting for renal failure and other comorbidities, this does not exclude the possibility that these HF patients had higher atherosclerotic burden over time as administrative codes control for presence of disease and not its severity. The hypothesis that recent increases in mortality for HF following AMI is due to selection of sicker patients who were hospitalized will need to be clinically confirmed in future studies.
Only 54.3% of patients hospitalized with HF hospitalization after AMI survived to one year in the final year of this contemporary cohort of older subjects. In comparison, 1-year survival after HF following AMI was modestly higher in other studies: 1-year survival was 72%
in the Olmsted County
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, and 1-year survival for HF in general in the Framingham Heart Study was 57% for men and 64% for women. 31 Clearly, older patients hospitalized for HF following AMI appear to be at higher risk for death, and as such this population may benefit from more frequent surveillance and in some cases more intense treatments. For example is has been wellestablished that older HF patients are less likely to be prescribed beta-blockers and inhibitors of the angiotensin-renin-aldosterone system, [32] [33] [34] [35] [36] [37] [38] Similarly, cardiac resynchronization therapy is effective in older patients 39, 40 but also underused. 36, 41 Compared with younger populations, older patients typically have the highest absolute risks for death after AMI and HF, and as result would receive the greatest absolute benefit from such therapies. Future studies should be AMI is due to selection of sicker patients who were hospitalized will need to be c c cli ini ni n ca ca all ll lly y y confirmed in future studies.
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Limitations
Our study has several potential limitations. We were not able to distinguish incident from prevalent cases of HF, and not able to separate patients with AMI complicated by HF from patients with prior HF who were admitted for AMI. We examined the Medicare fee-for service population, and trends in HF hospitalization rates following AMI may differ in younger patients or those with different health insurance. Third, HF ascertainment was not based on clinical criteria, and hospitals may have changed patterns of medical coding of HF over time;
comorbidities were ascertained from administrative codes and not clinically confirmed. Our study focused on HF hospitalizations and was not able to assess changes in HF care in outpatient clinics or emergency departments, and as such may have underestimated overall HF incidence rates. Although we were unable to differentiate systolic versus diastolic HF using administrative data, it is likely that most AMI patients who develop HF would have systolic dysfunction.
Conclusion
Using a complete sample of Medicare patients, our study found that the proportion of patients who developed HF following hospitalization for AMI decreased by 14.4% from 1998 to 2010. In contrast, the risk for death within 1 year after HF hospitalization following AMI decreased by a relative 3.4% annually from 1998 to 2007, but was followed by an annual relative increase of A AMI, acute myoc r r ardial a a i f nf r ar a t ctio i n; C CI, I, I c con onfi fi e denc nce e n in e te v v rval; F F HF, he h h art fa fa f l ilur u e 1-y yea ear r mort rtal ality amon ng g pa patients ts h s ospi pita tali lize z d for HF HF a aft fter er A AMI M 
